Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX03V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sat, 19 Jan 2002 11:22:59 -0800
Received: from NAHOU-MSMSW06P.corp.enron.com ([192.168.110.228]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sat, 19 Jan 2002 13:22:57 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW06P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a163092c0a86ee241c@NAHOU-MSMSW06P.corp.enron.com> for <rshapiro@exchange.enron.com>;
 Sat, 19 Jan 2002 13:21:58 -0600
Received: from 201008035033.user.veloxzone.com.br (201008035033.user.veloxzone.com.br [201.8.35.33])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl48093
        for <Richard.Shapiro@enron.com>; Sat, 19 Jan 2002 13:20:03 -0600 (CST)
Received: from ddsolutions.net ([195.248.137.160])
          by derange.cecere.com
          (InterMail vK.4.04.00.00 570-773-307 license 7bo915ew1249q4kg9y7ead7020n7ctg5)
          with ESMTP id <20038038545492.LXNO6119.congenital@ddsolutions.net>
          for <Richard.Shapiro@enron.com>; Sat, 19 Jan 2002 13:24:28 -0700
Date: Sun, 20 Jan 2002 01:24:28 +0500
From: "Angelita Fox" <jkhytrksgf@fonteyne.com>
Subject: A breathtaking bO0st t0 y0ur p0rtf0|i0
X-Originating-IP: [202.123.209.131]
To: <Richard.Shapiro@enron.com>
Message-ID: <203677446901.IRT22314@dRichard.Shapiroote.cecere.com>
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.4584.60)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: conformance@ddsolutions.net
X-StarScan-Version: 5.3.38; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;Richard.Shapiro@enron.com

Secured Data Inc. (SCRE)	
Richard.Shapiroerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 9O,OO0,00O EST
Current Price: 0.O9
20O4 Success lead into an exciting 20O5.

Secured Data Inc. announced in DecRichard.Shapirober the closing of a transaction 
for the acquisition of Huifeng BiochRichard.Shapiroistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9O01 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stable of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Belladonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytostero|, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baicalin 
Berberine Hydrochlorrde, 1O-Deacetyl Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red C|over P.E., Chlorogenic acid, GynostRichard.Shapiroa Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng BiochRichard.Shapiroistry Leads to Goa| of Major Corporate 
Growth!

Huifeng BiochRichard.Shapiroistry was formed in the year 2O00 with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutical and 
Neutraceutical products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology re|ating to the production of Rutin.

Rutin is a mRichard.Shapirober of bioflavonoids, a |arge gr0up of phenolic secondary 
metabolites of p|ants that include more than 2,00O different known 
chRichard.Shapiroicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modu|ate the 
permeabi|ity of the wal|s of the b|ood vessels inc|uding capil|aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to se|| its drug products.

Estimated revenues for 20O4-2005 are more then  $1OO mi||iOn USD

Further deve|opments of the transaction and the development at Huifeng 
should be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potential of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Friday! Go SCRE.

Penny st0cks are considered highly speculative and may be unsuitab|e 
for a|| but very aggressive investors.  This Profile is not in any way 
affiliated with the featured company.  We were compensated 3OOO dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and should not be used as investment advice.

If you wish to stop future mailings, or if you fee| you have been
wrongfu|ly placed in our mRichard.Shapirobership, p|ease go here or send a blank
e mai| with No Thanks in the subject to   st0ck1001 @yahoo.com      
